Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“In 69% of prescription drug labels, reporters found a generic drug manufacturer’s DUNS number.”
VerifiedConfidence: HIGH

Reasoning

The ProPublica article states that reporters, while collecting data for the Rx Inspector tool, found a generic drug manufacturer’s DUNS number on 69% of prescription drug labels and could link it to a specific facility. This directly confirms the claim.

On confidence: The claim is directly quoted in the provided ProPublica article excerpt.

Important context

The statistic refers to the proportion of prescription drug labels where a generic manufacturer’s DUNS number was identified by reporters using the Rx Inspector tool.

Evidence

Supporting (2)

Limitations

The evidence is limited to the single ProPublica source; no additional independent verification is provided.

Last verified:
Sep 27, 2026, 4:24 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate Vote

ProPublica · Naisha Roy